Chemomab Therapeutics (CMMB) P/E (2021 - 2026)
Chemomab Therapeutics (CMMB) P/E from Mar 31, 2021 to Jul 21, 2026. The TTM Chemomab Therapeutics (CMMB) P/E is -0.14. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Chemomab Therapeutics (CMMB)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.14 | -10.91% |
| 2025 | -0.15 | -77.21% |
| 2024 | -0.67 | +254.90% |
| 2023 | -0.19 | -87.44% |
| 2022 | -1.50 | -76.02% |
| 2021 | -6.25 | N/A |
Comparison Chemomab Therapeutics (CMMB) P/E with competitors
Chemomab Therapeutics (CMMB) P/E is -0.14.